Paul Angulo
Impact in
- Hepatology top 0.05%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 92
- Liver Diseases and Immunity 81
- Liver Disease and Transplantation 8
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Epidemiology 81
- Liver Disease Diagnosis and Treatment 80
- Co-authors
- Keith D. Lindor (105 shared papers)Leon Anton Adams (25 shared papers)Schuyler O. Sanderson (7 shared papers)Ariel E. Feldstein (14 shared papers)Jill C. Keach (17 shared papers)James F. Lymp (9 shared papers)Phunchai Charatcharoenwitthaya (14 shared papers)Jennifer L. St. Sauver (6 shared papers)
- Journals
- Hepatology (31 papers)The American Journal of Gastroenterology (30 papers)Gastroenterology (28 papers)Journal of Hepatology (16 papers)Digestive Diseases and Sciences (8 papers)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Paul Angulo
179 papers receiving 31.2k citations
Paul Angulo's Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 7k
- Epidemiology 21.2k
- Endocrinology, Diabetes and Metabolism 1k
- Pharmacology 466
- Surgery 1.8k
Countries citing papers authored by Paul Angulo
This map shows the geographic impact of Paul Angulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Angulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Angulo more than expected).
Fields of papers citing papers by Paul Angulo
This network shows the impact of papers produced by Paul Angulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Angulo. The network helps show where Paul Angulo may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Angulo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2002 | 4514 |
| 2 | The NAFLD fibrosis score Hit paper breakdown → | 2007 | 2642 |
| 3 | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2015 | 2491 |
| 4 | The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study Hit paper breakdown → | 2005 | 2462 |
| 5 | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hit paper breakdown → | 1999 | 1348 |
| 6 | Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Hit paper breakdown → | 2003 | 928 |
| 7 | The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies Hit paper breakdown → | 2004 | 782 |
| 8 | Non‐alcoholic fatty liver disease Hit paper breakdown → | 2002 | 696 |
| 9 | The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years Hit paper breakdown → | 2009 | 631 |
| 10 | Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial Hit paper breakdown → | 2004 | 598 |
| 11 | Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome Hit paper breakdown → | 2014 | 568 |
| 12 | 2004 | 434 | |
| 13 | Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2013 | 434 |
| 14 | Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis Hit paper breakdown → | 2015 | 427 |
| 15 | 2011 | 393 | |
| 16 | 2001 | 373 | |
| 17 | 2008 | 358 | |
| 18 | 2007 | 317 | |
| 19 | 2006 | 304 | |
| 20 | 2008 | 286 |
About Paul Angulo
Paul Angulo is a scholar working on Hepatology, Epidemiology, Orthopedics and Sports Medicine, Pharmacology and Statistics, Probability and Uncertainty, having authored 182 papers that have together received 32.7k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (81 papers), Liver Disease Diagnosis and Treatment (80 papers), Liver Disease and Transplantation (8 papers), Bone health and osteoporosis research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Hepatology (7k citations), Epidemiology (21.2k citations), Endocrinology, Diabetes and Metabolism (1k citations), Pharmacology (466 citations) and Surgery (1.8k citations). Paul Angulo has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Keith D. Lindor, Leon Anton Adams, Schuyler O. Sanderson, Ariel E. Feldstein, Jill C. Keach, James F. Lymp, Phunchai Charatcharoenwitthaya, Jennifer L. St. Sauver, Roberta A. Jorgensen and Einar Stefan Bjornsson. Their work appears in journals such as Hepatology, The American Journal of Gastroenterology, Gastroenterology, Journal of Hepatology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.